CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,555 | +7.1% | 10,500 | 0.0% | 0.00% | – |
| Q4 2022 | $8,925 | -0.8% | 10,500 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 10,500 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -41.2% | 10,500 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -32.0% | 10,500 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -51.0% | 10,500 | 0.0% | 0.00% | – |
| Q3 2021 | $51,000 | +82.1% | 10,500 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -12.5% | 10,500 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |